Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.21.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2021
Mar. 31, 2020
Current assets:    
Cash and cash equivalents $ 4,220 $ 3,691
Accounts receivable, net 2,806 3,973
Inventories 2,530 2,181
Prepaid expenses and other current assets 3,218 2,256
Current portion of deferred consideration, net of discount 209 182
Total current assets 12,983 12,283
Property and equipment, net 360 365
Operating lease, right of use assets 769 359
Deferred consideration, net of discount, less current portion 763 786
Non-current assets held for sale 0 704
Other assets 112 64
Total assets 14,987 14,561
Current liabilities:    
Accounts payable 1,769 2,067
Accrued expenses and other current liabilities 1,154 1,774
Deferred revenue 267 228
Deferred revenue Invekra (Note 4) 52 45
Current portion of long-term debt 596 481
Operating lease liabilities 240 134
Total current liabilities 4,078 4,729
Long-term deferred revenue Invekra 229 245
Long-term debt, less current portion - PPP 1,310 0
Withholding Tax Payable 3,478 3,082
Liabilities associated with assets currently held for sale 0 646
Operating lease liabilities, less current portion 529 235
Total liabilities 9,624 8,937
Commitments and Contingencies (Note 13)
Stockholders' Equity    
Convertible preferred stock, $0.0001 par value; 714,286 shares authorized at March 31, 2021 and March 31, 2020, respectively, 0 and 1.55 shares issued and outstanding at March 31, 2021 and March 31, 2020, respectively 0 0
Common stock, $0.0001 par value; 24,000,000 shares authorized at March 31, 2021 and March 31, 2020, respectively, 2,092,909 and 1,777,483 shares issued and outstanding at March 31, 2021 and March 31, 2020, respectively (Note 14) 2 2
Additional paid-in capital 189,217 186,559
Accumulated deficit (179,277) (175,327)
Accumulated other comprehensive loss (4,579) (5,610)
Total stockholders' equity 5,363 5,624
Total liabilities and stockholders' equity $ 14,987 $ 14,561